Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for Hard-to-Treat depression in seniors: esketamine spray vs aripiprazole Results expected Sep 2026 (estimated)
- Lifestyle overhaul tested as fatty liver fix Results expected Nov 2026 (estimated)
- Same-Day discharge for severe appendicitis? new trial aims to cut hospital stays Results expected Sep 2027 (estimated)
-
Can a Salt-Marsh plant extract help control cholesterol?
Disease control Not yet recruitingThis study tests whether a dietary supplement made from halophyte plant extracts (like salicornia) and B vitamins can improve cholesterol levels in people recently diagnosed with dyslipidemia who do not yet need medication. About 250 participants will take the supplement or follo…
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Could a heart drug beat a deadly blood infection? new trial aims to find out
Disease control Not yet recruitingThis study tests whether adding clopidogrel, a drug usually used to prevent blood clots, to standard antibiotics improves outcomes for adults with a serious Staphylococcus aureus bloodstream infection. About 230 hospitalized patients will be randomly assigned to receive clopidogr…
Phase 2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
AI-Powered therapy for teens shows promise in new trial
Symptom relief Not yet recruitingThis study tests AGENCIA, a brief psychological program supported by digital technology and artificial intelligence, to help teens aged 12-18 with emotional and behavioral difficulties like irritability, impulsivity, and conflicts. Participants are randomly assigned to an online …
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New hope for Hard-to-Treat depression in seniors: esketamine spray vs aripiprazole
Symptom relief Not yet recruitingThis study compares two add-on treatments—esketamine nasal spray and aripiprazole pills—for older adults (60-74) whose depression hasn't improved with standard antidepressants. Around 220 participants will receive either esketamine once or twice weekly or daily aripiprazole, alon…
Phase 3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated Jun 26, 2026 13:33 UTC
-
New study aims to predict deadly infections in blood cancer patients
Knowledge-focused Not yet recruitingThis study looks at blood cancer patients who carry drug-resistant bacteria in their gut. Researchers want to find out who is most likely to get a serious infection from these bacteria. They will collect rectal swabs and track patients for 90 days to build a prediction tool. The …
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC